Heart Rate Variability in White Coat Hypertension and Essential Hypertension (NCT00286884) | Clinical Trial Compass
CompletedNot Applicable
Heart Rate Variability in White Coat Hypertension and Essential Hypertension
Denmark65 participants
Plain-language summary
The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.
Who can participate
Age range30 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age 30-70 years
* office BP \>150/95 mmHg and 24-h ambulatory BP =/\>135/85 mmHg
* office BP \>150/95 mmHg and 24-h ambulatory BP \<135/85 mmHg
* office BP \<150/95 mmHg and 24-h ambulatory BP \<135/85 mmHg
Exclusion Criteria:
* Clinical signs of disease of the heart, lungs, liver, kidneys, brain or endocrine organs
* neoplastic disease
* daily use of medicine
* alcohol abuse
* abnormal laboratory screening including blood-hemoglobin, blood-white cell count, plasma-creatinine, plasma-alanine-amino-transaminases, plasma-albumin, plasma-sodium, plasma-potassium, urinary glucose, urinary albumin; electrocardiogram
* pregnancy
* unwillingness to participate